NEUROGENIC DETRUSOR OVERACTIVITY

Clinical trials for NEUROGENIC DETRUSOR OVERACTIVITY explained in plain language.

Never miss a new study

Get alerted when new NEUROGENIC DETRUSOR OVERACTIVITY trials appear

Sign up with your email to follow new studies for NEUROGENIC DETRUSOR OVERACTIVITY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New bladder injection trial offers hope for spinal injury patients

Disease control Recruiting now

This early-stage study is testing a new drug called EG110A, given as injections into the bladder wall, for adults with spinal cord injuries who experience frequent urine leaks. The main goals are to see if the treatment is safe and to find the right dose. Researchers will also ch…

Matched conditions: NEUROGENIC DETRUSOR OVERACTIVITY

Phase: PHASE1, PHASE2 • Sponsor: EG 427 • Aim: Disease control

Last updated Mar 30, 2026 14:31 UTC

NEUROGENIC DETRUSOR OVERACTIVITY

Get alerted when new NEUROGENIC DETRUSOR OVERACTIVITY trials appear

New bladder injection trial offers hope for spinal injury patients